A Phase 3, Randomized, Double-blind Trial of Pembrolizumab Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).
2020 Quality Statement
“Excellence in Care”
The provision of excellent care to Riverina Cancer Care Centre (RCCC) patients is achieved by Centre staff and Volunteers’ participation in and observance of the Centre’s Quality system in the performance of their roles. Cooperation, collaboration, communication and mutual respect are critical to provision of excellent care.